ARS Pharmaceuticals annual operating expenses
2020
2021
2022
2023
2024
2025
ARS Pharmaceuticals Operating Expenses Growth & History (SPRY)
ARS Pharmaceuticals's operating expenses was $263.7M for fiscal 2025.
View full ARS Pharmaceuticals company overviewARS Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $263.7M | $171.5M | +185.94% |
| 2024 | 2024-12-31 | $92.2M | $24.7M | +36.54% |
| 2023 | 2023-12-31 | $67.5M | $30.7M | +83.40% |
| 2022 | 2022-12-31 | $36.8M | $11.9M | +47.56% |
| 2021 | 2021-12-31 | $25.0M | −$8.0M | −24.18% |
| 2020 | 2020-12-31 | $32.9M | — | — |
ARS Pharmaceuticals quarterly operating expenses
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $95.1M | $31.8M | +50.20% |
| Q1 2026 | 2026-03-31 | $82.8M | $37.7M | +83.45% |
| Q4 2025 | 2025-12-31 | $69.6M | $30.2M | +76.60% |
| Q3 2025 | 2025-09-30 | $85.7M | $61.9M | +259.81% |
| Q2 2025 | 2025-06-30 | $63.3M | $47.5M | +299.82% |
| Q1 2025 | 2025-03-31 | $45.1M | $32.0M | +242.25% |
| Q4 2024 | 2024-12-31 | $39.4M | $29.2M | +285.14% |
| Q3 2024 | 2024-09-30 | $23.8M | $5.8M | +32.47% |
| Q2 2024 | 2024-06-30 | $15.8M | −$4.8M | −23.16% |
| Q1 2024 | 2024-03-31 | $13.2M | −$5.5M | −29.58% |
| Q4 2023 | 2023-12-31 | $10.2M | −$5.2M | −33.78% |
| Q3 2023 | 2023-09-30 | $18.0M | $11.2M | +163.65% |
| Q2 2023 | 2023-06-30 | $20.6M | $13.8M | +202.78% |
| Q1 2023 | 2023-03-31 | $18.7M | $11.0M | +141.34% |
| Q4 2022 | 2022-12-31 | $15.4M | — | — |
| Q3 2022 | 2022-09-30 | $6.8M | −$15.9M | −69.94% |
| Q2 2022 | 2022-06-30 | $6.8M | −$17.7M | −72.22% |
| Q1 2022 | 2022-03-31 | $7.8M | −$11.1M | −58.90% |
| Q3 2021 | 2021-09-30 | $22.7M | $14.6M | +179.60% |
| Q2 2021 | 2021-06-30 | $24.5M | $18.0M | +279.25% |
| Q1 2021 | 2021-03-31 | $18.9M | $13.6M | +260.26% |
| Q4 2020 | 2020-12-31 | $13.1M | — | — |
| Q3 2020 | 2020-09-30 | $8.1M | — | — |
| Q2 2020 | 2020-06-30 | $6.5M | — | — |
| Q1 2020 | 2020-03-31 | $5.2M | — | — |
ARS Pharmaceuticals operating expenses trends
Over the last five fiscal years, ARS Pharmaceuticals's operating expenses increased from $32.9M to $263.7M, a change of $230.8M. The latest reported quarter, Q2 2026, shows $95.1M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ARS Pharmaceuticals source filings ↗